Important change to the number of vials per package for MenQuadfi® Meningococcal (Groups A, C, Y, W) Conjugate Vaccine

2019 AIPO

Important change to the number of vials per package for MenQuadfi® Meningococcal (Groups A, C, Y, W) Conjugate Vaccine

Package Icon

What will change?

  • Number of vials per package:  There will be 10 vials per package instead of the previous 5 vials per package.
  • Ordering: Packages containing 5 vials will no longer be available to order in ASIIS after the transition date.
  • Package size: The package size will change to 85 mm x 51 mm x 46 mm.
  • Package National Drug Code (NDC): The carton NDC will change from 49281-0590-05 for the 5-vial carton to 49281-0590-10 for the 10-vial carton, a change that reflects the number of vials included.
Vial Icon

 There is no change to:

  • MenQuadfi® formulation: The MenQuadfi® formulation will remain the same.
  • MenQuadfi® indication for use: MenQuadfi® is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. MenQuadfi® is approved for use in individuals 2 years of age and older. MenQuadfi does not prevent N. meningitidis serogroup B disease.
  • MenQuadfi® Current Procedural Terminology (CPT) code: 90619
Calendar Icon

  Timeline:

  • We anticipate the transition will occur in August 2024.
  • After the transition date, packages containing 5 vials will no longer be available to order in ASIIS, and subsequent orders will be shipped as packages of 10 vials.
MenQuadfi® Packaging

 Please see the full prescribing information for MenQuadfi®